首页> 外文期刊>Chinese Jouranl of Integrative Medicine >Effects of Rebixiao Granules on Blood Uric Acid in Patients with Repeatedly Attacking Acute Gouty Arthritis
【24h】

Effects of Rebixiao Granules on Blood Uric Acid in Patients with Repeatedly Attacking Acute Gouty Arthritis

机译:瑞必消颗粒对反复发作的急性痛风性关节炎患者血尿酸的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Objective: To observe the clinical effect of Rebixiao granule (RBXG) in treating repeatedly attacking acute gouty arthritis and through experimental study on blood uric acid to explore RBXGs therapeutic mechanism. Methods: Ninety repeatedly attacking acute gouty arthritis patients were divided into the treated group (n = 60) and control group (n = 30). The treated group was treated with RBXG, and the control group was treated with Futalin tablets (diclofenac sodium). The baseline treatment including good rest, low purine diet, sufficient water drinking and urine alkalization, etc. was then given to both groups. Hypoxanthine 600 mg/kg and niacin 100 mg/kg was applied to hyperuricemic mice by gastroga-vage to establish the animal models. Results: The clinical effective rate of the treated group was 95.0% and that of the control 90.0% . Good therapeutic effects were won, insignificant difference (P > 0.05) was shown between the two groups. However, the cure rate of the treated group was 26.7% while that of the control group was 10.0%, with significant difference (P< 0.01) shown between them. The treated group had its blood uric acid lowered, which was significantly different (P< 0.05) from that of the control group. The animal experiment indicated that all the three groups treated with different dosages of RBXG, as well as the Ash bark and Smilax glabra rhizome groups had their blood uric acid content reduced in the hyperuricemic mice. Conclusion: RBXG has a quicker initiation and better treatment effects than sole anti-inflammatory and analgesic agents on the treatment of repeatedly attacking acute gouty arthritis, showing no obvious toxic or adverse reactions and therefore good for long-term administration and likely to be a safe TCM preparation to control the symptoms and reduce the onsets of repeatedly attacking of acute gouty arthritis. The animal experiment shows that both the compound preparation and part of the single ingredients in the recipe have the function of reducing blood uric acid. However, the compound recipe has better therapeutic effects, proving to be superior to single drugs.
机译:目的:观察热痹消颗粒(RBXG)治疗反复发作的急性痛风性关节炎的临床疗效,并通过血尿酸实验研究探讨其治疗机理。方法:将90例反复发作的急性痛风性关节炎患者分为治疗组(n = 60)和对照组(n = 30)。治疗组用RBXG治疗,对照组用富他林片剂(双氯芬酸钠)治疗。然后对两组进行基线治疗,包括良好的休息,低嘌呤饮食,充足的饮水和尿碱化等。将次黄嘌呤600 mg / kg和烟酸100 mg / kg通过胃管灌胃法用于高尿酸血症小鼠,以建立动物模型。结果:治疗组临床有效率为95.0%,对照组为90.0%。两组均获得了良好的治疗效果,差异无统计学意义(P> 0.05)。然而,治疗组的治愈率为26.7%,而对照组的治愈率为10.0%,两者之间有显着性差异(P <0.01)。治疗组的血尿酸水平降低,与对照组相比差异有统计学意义(P <0.05)。动物实验表明,用不同剂量的RBXG处理的三组,以及灰树皮和光滑的根茎组在高尿酸血症小鼠中的血尿酸含量均降低。结论:RBXG在反复发作的急性痛风性关节炎的治疗中,比单独的消炎和止痛药起效快,且具有更好的治疗效果,无明显毒性或不良反应,因此长期服用很可能是安全的。中药制剂可控制症状并减少急性痛风性关节炎反复发作的发作。动物实验表明,化合物制剂和配方中的部分单一成分均具有降低血尿酸的功能。但是,该复合配方具有更好的治疗效果,被证明优于单一药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号